DreaMed Diabetes
6
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
16.7%
1 terminated/withdrawn out of 6 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Role: lead
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
Role: collaborator
Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1
Role: collaborator
Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept Studies
Role: collaborator
DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy
Role: lead
Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections
Role: lead
All 6 trials loaded